首页> 外文期刊>Antioxidants and redox signalling >PGC-1 alpha/ERR alpha-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase beta
【24h】

PGC-1 alpha/ERR alpha-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase beta

机译:PGC-1 alpha / ERR alpha-Sirt3通路通过直接使SOD2和ATP合酶β脱乙酰化来调节DA能神经元死亡

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims: Parkinson's disease (PD) heavily affects humans and little is known about its cause and pathogenesis. Sirtuin 3 (Sirt3) plays a key role in regulating mitochondrial dysfunction, which is the main cause of DAergic neuronal loss in PD. We investigated the mechanisms of neuroprotective role of Sirt3 in DAergic neuronal survival. Results: Sirt3 was reduced in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP)-treated neurons with its overexpression being neuroprotective. We identified that Sirt3 interacted with manganese superoxide dismutase (SOD2) and adenosine triphosphate (ATP) synthase and modulated their activities by deacetylating SOD2 (K130) and ATP synthase (K485) to prevent reactive oxygen species accumulation and ATP depletion, and to alleviate DAergic neuronal death upon MPTP treatment. Peroxisome proliferator-activated receptor- coactivator 1 (PGC-1) interacted with estrogen-related receptor alpha (ERR) that bound to the Sirt3 promoter as its transcription factor to regulate Sirt3 expression and DAergic neuronal death. In the mouse midbrain, MPTP administration led to the loss of PGC-1 and Sirt3, high acetylation level of SOD2 and ATP synthase , and the specific loss of DAergic neurons, while Sirt3 overexpression could protect against DAergic neuronal loss. Sirt3 knockout mice exhibited more sensitive and more DAergic neuronal loss to MPTP treatment. Innovation: The study provides new insights into a critical PGC-1/ERR-Sirt3 pathway, linking regulation of mitochondrial protein acetylation and DAergic neuronal death in PD pathogenesis, which provide a potential therapeutic strategy and target in PD treatment. Conclusion: These results provide a vital PGC-1/ERR-Sirt3 pathway that protects against DAergic neuronal death by directly deacetylating SOD2 (K130) and ATP synthase (K485) in PD. Antioxid. Redox Signal. 24, 312-328.
机译:目的:帕金森氏病(PD)严重影响人类,对其病因和发病机制知之甚少。 Sirtuin 3(Sirt3)在调节线粒体功能障碍中起关键作用,线粒体功能障碍是PD中DA能神经元丢失的主要原因。我们调查了Sirt3在DA能神经元生存中的神经保护作用的机制。结果:Sirt3在1-甲基-4-苯基-1,2,3,6四氢吡啶(MPTP)处理的神经元中被还原,其过表达具有神经保护作用。我们确定Sirt3与锰超氧化物歧化酶(SOD2)和三磷酸腺苷(ATP)合酶相互作用,并通过使SOD2(K130)和ATP合酶(K485)脱乙酰化来调节其活性,从而防止活性氧的积累和ATP的消耗,并减轻DA能神经元MPTP治疗导致死亡。过氧化物酶体增殖物激活受体共激活因子1(PGC-1)与雌激素相关受体α(ERR)相互作用,后者以Sirt3启动子作为转录因子来调节Sirt3表达和DAergic神经元死亡。在小鼠中脑中,MPTP给药导致PGC-1和Sirt3的丧失,SOD2和ATP合酶的高乙酰化水平以及DAergic神经元的特异性丧失,而Sirt3过表达可以防止DAergic神经元的丧失。 Sirt3基因敲除小鼠对MPTP治疗表现出更敏感和更多的DA能神经元丢失。创新:这项研究为关键的PGC-1 / ERR-Sirt3途径提供了新见解,将线粒体蛋白乙酰化的调节与PD发病机理中的DA能神经元死亡联系起来,为PD治疗提供了潜在的治疗策略和目标。结论:这些结果提供了一条至关重要的PGC-1 / ERR-Sirt3途径,该途径可通过直接使PD中的SOD2(K130)和ATP合酶(K485)脱乙酰基来防止DA能神经元死亡。抗氧化。氧化还原信号。 24,312-328。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号